Airway Obstruction clinical trials at UCLA
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The objective of ILAN is to assess the safety, feasibility and bronchodilator efficacy of in-line bronchodilator nebulizer delivery with VMN via HFNC system in hypoxemic respiratory failure patients treated with bronchodilators and compare this method to standard-nebulization using a jet nebulizer with a facial mask. The investigators hypothesized that aerosol nebulization using HFNC/VMN represents safer and more convenient approach in hypoxemic respiratory failure patients in comparison to conventional therapy while providing similar bronchodilator efficacy.
Our lead scientists for Airway Obstruction research studies include Igor Barjaktarevic, MD, PhD.